Mr. Goodman is currently the Director of Information Technologies for the Interstate Companies, a Memphis, TN based company. Interstate is a group of privately held plasma and whole blood collection centers in the United States. Goodman’s 30+ years of experience in large scale business process automation and project management is being leveraged as Interstate transitions its operations from manual center processes to fully automated donor management systems. This included the design and implementation of donor compensation systems that transitioned from cash to prepaid cards. Goodman works closely with information technology vendors to design and implement innovative solutions that are mutually beneficial to the vendors and to Interstate, and has previously served on the Customer Advisory Councils of innovative technology companies such as Citrix, CDW and Wyse Technologies.

Prior to his current position at Interstate, Goodman served as an Information Systems Director at Baptist Memorial Health Care Corporation in Memphis from 1996 thru 2008. From 1982 to 1996, Goodman owned and operated Matrix Management, Inc., a value-added reseller of turn-key automation systems for the medical and construction industries. He attended the University of Texas – Austin and The University of Memphis and holds a Bachelor of Business Administration.

“In order to provide the innovative solutions 3PEA is known for, it is imperative that we have relevant, timely insight into the dynamic nature of the industries we serve,” said Mark Newcomer, Chairman and CEO of 3PEA International. “Lenny’s insight and feedback will help ensure that 3PEA continues to provide the plasma industry with the most innovative, user friendly payment solutions available.”

“3PEA International has proven itself to be a company that strives to fully understand the needs of their customers and the industries in which they compete in order to provide the highest level of services,” said Goodman. “I look forward to assisting 3PEA as they continue to provide high availability innovative payment solutions to the plasma industry and beyond.”

About 3PEA International

3PEA International (OTCBB: TPNL) is an experienced and trusted prepaid debit card payment solutions provider as well as an integrated payment processor that has millions of prepaid debit cards in its portfolio. Through its PaySign brand, 3PEA designs and develops payment solutions, prepaid card programs, and customized payment services. 3PEA manages programs for many of the world’s largest pharmaceutical manufacturers with copay assistance products designed to maximize new patient acquisition, retention and adherence. 3PEA’s corporate incentive prepaid cards are changing the way corporations reward, motivate and engage their current and potential customers, employees and agents. 3PEA’s customizable prepaid solutions offer significant cost savings while improving brand recognition and customer loyalty. 3PEA’s customers include healthcare companies, major pharmaceutical companies and source plasma providers, large multinationals, prestigious universities and social media companies. PaySign is a registered trademark of 3PEA Technologies, Inc. in the United States and other countries. For more information visit us at paysign.com or follow us on LinkedIn, Twitter and Facebook.

Forward-Looking Statements

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the companies, are forward-looking statements that involve risks and uncertainties. There is no assurance that such statements will prove to be accurate, and actual results and future events could differ materially. 3PEA undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events, or otherwise.